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Membrane remodelingThe CLIC proteins are a highly conserved family of metazoan proteins with the unusual ability to adopt both sol-
uble and integral membrane forms. The physiological functions of CLIC proteins may include enzymatic activity
in the soluble form and anion channel activity in the integral membrane form. CLIC proteins are associated with
the ERMproteins: ezrin, radixin andmoesin. ERM proteins act as cross-linkers betweenmembranes and the cor-
tical actin cytoskeleton. Both CLIC and ERM proteins are controlled by Rho family small GTPases. CLIC proteins,
ERM and Rho GTPases act in a concerted manner to control active membrane processes including the mainte-
nance ofmicrovillar structures, phagocytosis and vesicle trafﬁcking. All of these processes involve the interaction
ofmembraneswith the underlying cortical actin cytoskeleton. The relationships between Rho GTPases, CLIC pro-
teins, ERM proteins and the membrane:actin cytoskeleton interface are reviewed. Speculative models are pro-
posed involving the formation of localised multi-protein complexes on the membrane surface that assemble
via multiple weak interactions. This article is part of a Special Issue entitled: Reciprocal inﬂuences between cell
cytoskeleton and membrane channels, receptors and transporters. Guest Editor: Jean Claude Hervé.
© 2013 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 644
2. The players — description of the characters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 644
2.1. CLIC proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 644
2.2. ERM: ezrin, radixin and moesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 646
2.3. Rho family small GTPases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 647
2.4. NADPH oxidase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 647
2.5. PI(4,5)P2 & PIP5K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3. Setting the scene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3.1. Plasma membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3.1.1. Ezrin, microvilli & vesicular trafﬁcking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3.1.2. CLIC5, ERM, the actin cytoskeleton & microvilli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3.1.3. CLIC5, radixin & stereocilia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 648
3.1.4. CLIC5, ezrin & the maintenance of the ﬁltration barrier in the kidney . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 649
3.1.5. CLIC4, ezrin & the apical microvilli of the occular retinal pigment epithelium . . . . . . . . . . . . . . . . . . . . . . . . 649
3.2. Intracellular membranes & tubulogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 649
3.2.1. Exc phenotype in C. elegans: CLIC-like proteins, ERM, Rho & cytoskeleton . . . . . . . . . . . . . . . . . . . . . . . . . 649
3.2.2. CLIC4 & tubulogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 649al inﬂuences between cell cytoskeleton and membrane channels, receptors and transporters. Guest Editor: Jean Claude Hervé.
ity of New South Wales, Sydney, NSW 2052, Australia. Tel.: +61 2 9385 4552; fax: +61 2 9385 6060.
i).
rights reserved.
644 L. Jiang et al. / Biochimica et Biophysica Acta 1838 (2014) 643–6574. Action! . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
4.1. CLIC4, NHERF2, RhoA & translocation to the plasma membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
4.2. CLIC1, amyloid & translocation to the plasma membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
4.3. CLIC1, ERM, Rho, Rac & phagocytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
4.4. CLIC3 & the sorting/recycling of intracellular vesicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
5. Is there a smoking gun? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 650
5.1. Multiple weak interactions and coincidence signalling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 651
5.2. Do Rho GTPases activate ERM by direct binding? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 651
5.3. Unstructured cytoplasmic domains: “string binding” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 652
5.4. Are CLIC proteins soluble, cytoplasmic proteins or are they components of intracellular vesicles? . . . . . . . . . . . . . . . . . . . . 652
5.5. Do CLIC proteins function as ion channels in intracellular vesicles? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 652
5.6. A speculative model for the assembly of a membrane-bound complex including CLIC, ERM, RhoGTPase . . . . . . . . . . . . . . . . 653
6. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 653
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 654
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6541. Introduction
Since their discovery, the Chloride Intracellular Channel proteins
(CLICs2) have challenged our preconceptions of what constitutes an
ion channel membrane protein versus a cytosolic globular protein
[1–10]. Although ﬁrst identiﬁed and cloned as chloride ion channels
[9–11], the sequences of CLIC proteins do not resemble those of
more conventional ion channel proteins. This has given rise to contin-
ued debate as to whether the CLICs function as ion channels or have
other, possibly additional, non-channel cellular functions [12–15].
Three things are clear: ﬁrst, while being largely soluble proteins,
CLICs can localise to cell membranes or lipid bilayers under speciﬁc
conditions. Second, the localisation of CLIC proteins to cell mem-
branes is often associated with processes that involve membrane
remodelling mediated by the cortical actin cytoskeleton and third,
the CLIC proteins are associated with small GTPases. These three
points are the central concerns of this review.
2. The players — description of the characters
2.1. CLIC proteins
The CLIC proteins are a family that is conserved throughoutmetazoa.
In vertebrates, there are usually six CLIC paralogues, CLIC1–6, that have
arisen froma single chordate CLIC [13]. These vertebrate CLIC paralogues
appear to have diversiﬁed in function with some CLICs (CLIC1 and
CLIC4) appearing in a wide range of cells while others have a more lim-
ited distribution (CLIC5, CLIC6). CLIC-like proteins (usually one) appear
to be present in all invertebrate metazoa. The fruit ﬂy, Drosophila
melanogaster, has a single CLIC-like protein (DmCLIC) [16], while the
nematode, Caenorhabditis elegans, has two, Exc-4 and Exl-1 [17,18].
The recently sequenced genomes of choanoﬂagellates [19] (the closest
single celled organisms to metazoa) indicate that they also have a
CLIC-like gene.
All CLIC proteins contain a ~240 residue CLIC module that adopts a
GST superfamily fold [20,21]. This consists of an N-terminal thioredoxin
fold followed by an allα helical C-terminal domain (Fig. 1A & B). Unlike
most GSTs, most CLIC proteins contain a conserved cysteine residue at
what structurally looks to be an enzymatic active site [13,22]. This site
resembles that of glutaredoxin, including the sequence motif: Cys-2 Abbreviations: CLIC— Chloride Intracellular Channel protein; ERM— ezrin, radixin,
moesin family protein; WT — wild type; NADPH - nicotinamide adenine dinucleotide
phosphate; ROS — reactive oxygen species; PIP5K — Phosphatidylinositol-4-phos-
phate-5-kinase; PI(4,5)P2 — phosphatidylinositol 4,5-bisphosphate; FERM — band
4.1, ezrin, radixin, moesin domain; C-ERMAD — C-terminal ezrin, radixin, moesin
actin-binding domain; GAP — GTPase accelerating protein; GEF — guanine exchange
factor; GDI — guanosine nucleotide dissociation inhibitor; TM — transmembrane;
PTM— putative transmembrane region; FRET— ﬂuorescence resonant energy transfer;
CRIg — complement receptor of the immunoglobulin.Pro-Phe-Ser/Cys [20]. The active site cysteine (Cys24 in human CLIC1)
is conserved in all CLICs with the notable exception of the two
CLIC-like proteins in C. elegans and related nematodes, where the cyste-
ine is replaced by aspartate [17,18]. There are two additional cysteine
residues that are conserved in all CLICs (Cys178 and Cys223, human
CLIC1 numbering). As predicted from the crystal structure, redox
(reduction-oxidation processes) appears to be important for CLIC pro-
tein function [16,23–35].
The traditional view of proteins is that their sequence determines
a unique, well-deﬁned three dimensional structure [36]. However, re-
cent work has discovered a growing class called metamorphic pro-
teins that can adopt more than one well-deﬁned three dimensional
structure [37–39]. CLICs are metamorphic proteins, being able to un-
dergo reversible conformational transitions to adopt several, stable,
well-deﬁned three-dimensional conﬁgurations.
Under reducing conditions, CLIC1 is a soluble monomer with a GST
fold. Under oxidising conditions, a minor conformer is trapped and
populated, revealing a non-covalent dimer, which is stabilised by an in-
tramolecular disulphide bond [33]. The dimer interface is highly hydro-
phobic implying that a monomer with this conformation would be
highly unstable in aqueous solution. The structure of the oxidised
dimer reveals a dramatic rearrangement of the N-terminal thioredoxin
fold domain where the four-stranded β sheet has been replaced by an
all-helical structure (Fig. 1C) [33]. Biophysical studies have shown that
the N-terminal domain of CLIC1 is conformationally plastic with its
structural stability reducing at low pH [40–43].
CLIC proteins bind to artiﬁcial lipid bilayers. Studies using surface
plasmon resonance (SPR) have measured the binding of human CLICs
(CLIC1 [16] and CLIC4 [32]) and invertebrate CLIC-like proteins (Exc-4
and DmCLIC [16]) to membranes in a concentration dependent man-
ner. Membrane binding of these CLIC and CLIC-like proteins increases
with acidic pH and under oxidising conditions [26]. This correlates
with the oxidation-triggered structural transition observed in CLIC1
[33] and the conformational instability of CLIC1 at low pH values
[40–43].
CLIC proteins can spontaneously integrate into lipid bilayers. While
direct integration of a soluble protein into amembrane is not a common
property, there are large classes of proteins that possess this ability
including bacterial pore forming toxins [44], annexins and the Bcl-2
family of apoptotic proteins [45].
The ﬁrst identiﬁed CLIC protein, originally called p64, was puriﬁed to
homogeneity and subsequently cloned on the basis of its capacity to
form chloride ion channels [9–11]. Since then, several independent
groups have demonstrated the integration of CLIC proteins into bilayers
using electrophysiological studies based on bacterially-expressed, solu-
ble CLICs and artiﬁcial lipid bilayers [16,20,29–33,46–49]. The probabil-
ity of observing channel activity increaseswith decreasing pH [16,32,47]
and oxidising conditions [16,32]. In the case of CLIC1, mutation of the







Fig. 1. CLIC and ERM protein structure. A: Diagram showing conserved features of CLIC proteins using human CLIC1 sequence numbering. B: Ribbon diagram of the overall crystal
structure of reduced, monomeric CLIC1 (PDB ID: 1K0M) showing the GST fold that contains a thioredoxin-like N-terminal domain (β-strands s1-s4 and α helices h1-h3) and an
all α-helical C-terminal domain (α helices h4-h9). The PTM region, residues 24–46, (shown in magenta) comprises helix h1 and β-strand s2. The conserved cysteine residues:
Cys24, Cys178 and Cys223 (human CLIC1 sequence numbering) are presented as green stick models. C: The structure of the soluble half-dimer produced on oxidising CLIC1. The
N-terminal domain of CLIC1 undergoes a radical structural arrangement to an all α-helical domain (PDB ID: 1RK4). D: The domain organisation of ERM proteins using human
ezrin sequence numbering. Overall, the ERM proteins consist of: the ~300 residues FERM domain at the N-terminus (where F1, F2 and F3 are the three subdomains of the
FERM); the ~200 residue α-helical domain that contains a coiled-coil and a proline-rich (PP) linker region (the proline-rich region exists only in ezrin and radixin); and the
~100 residue C-ERMAD which contains the phosphorylation site (Thr567 in human ezrin) and the F-actin binding site. E: The crystal structure of full-length Spodoptera frugiperda
moesin (Sfmoesin) in the inactive state (PDB ID: 2I1K), showing the three subdomains of FERM: F1 (pink), F2 (green) and F3 (cyan), the α-helical domain (yellow) and the
C-ERMAD domain (red). The three binding sites on the FERM domain are indicated by the black arrows. Site 1 is the PI(4,5)P2 binding site which in the inactive ERM is occupied
by the linker region. Site 2 binds the cytoplasmic extensions of integral membrane proteins (such as CD43, CD44, ICAM-1, PSGL-1). Site 3 is the C-ERMAD/NHERF binding site.
645L. Jiang et al. / Biochimica et Biophysica Acta 1838 (2014) 643–657conductance and resulted in the CLIC protein being no longer redox
sensitive [31].
Despite being poorly selective between anions and cations, CLIC4
also displayed redox sensitivity, as did a truncated N-terminal version
of the protein containing the active cysteine [29]. The presence of the
reactive site cysteine may be a further factor controlling the transition
of the soluble CLIC state to the membrane bound form. Thus, the elec-
trophysiological observation of ion channels follows conditions where
the CLIC protein structure is less stable and the proteins have a propen-
sity to bind to membranes.Insertion of CLIC proteins into membranes is affected by lipid com-
position [48], especially cholesterol [31,48,50]. Recent studies using
tethered bilayer membranes and Langmuir monolayer ﬁlms show that
both the interaction with membranes and the conductance activity
due to CLIC1 are sensitive to the presence of cholesterol in the mem-
brane [50]. The addition of cholesterol to soluble CLIC1 prevents this in-
teraction with membranes. This is reminiscent of the spontaneously
membrane-inserting bacterial toxins – the cholesterol-dependent-
cytolysins – which are believed to interact with membranes via
cholesterol-rich rafts [51].
646 L. Jiang et al. / Biochimica et Biophysica Acta 1838 (2014) 643–657Since the discovery of the CLICs, it has been debated whether CLIC
proteins form ion channels by themselves or form elements controlling
integral membrane ion channels. For example, CLIC2 has been shown
to modulate the ryanodine receptor calcium release channel [52,53],
binding to its cytoplasmic face [54]. However, the above studies using
recombinant CLIC proteins clearly show that CLICs are indeed channel
proteins, at least in vitro.
The electrophysiological characteristics of the CLIC channels pro-
duced by recombinant proteins and artiﬁcial bilayers correspond
with the channel properties observed in cells expressing CLIC pro-
teins [20,47]. These include the effects of the chloride ion channel in-
hibitor indanyloxyacetic acid-94 (IAA94) which was used to both
identify and when coupled to sepharose, purify the original CLIC pro-
tein (bovine CLIC5B, initially called p64 from the bovine kidney cortex
membrane) [9–11]. Thus, although the mechanism is incompletely
understood, it is likely that CLIC proteins form ion channels in vivo.
Ion channel activity for CLIC proteins has been detected in cells, as
well as in artiﬁcial systems using puriﬁed proteins. When expressed
in CHO cells, CLIC1 forms an ion channel in the plasma membrane,
spanning the membrane so that the N-terminus is extracellular and
the C-terminus cytoplasmic [55]. This was determined by studying
the chloride conductance of CHO cells transfected with CLIC1 con-
structs bearing either an N or C-terminal epitope tag. Ion channel con-
ductance could only be blocked by anti-tag antibodies when on the
same side of the membrane as the epitope tag.
Based on sequence analysis, the putative transmembrane domain
(PTM) of CLIC proteins is thought to form a single membrane spanning
helix in the channel state, corresponding to the region Cys24-Val46 of
CLIC1 (Fig. 1A & B) [7–9]. The ﬁrst experimental evidence for this PTM
came with the discovery of CLIC4 which behaved as an integral mem-
brane protein [8]. Proteinase K digestion of intact microsomes
containing CLIC4 showed a ~27 kDa reduction in molecular weight on
SDS PAGE, leaving ~6 kDa fragment in the membrane, which presum-
ably included the PTM. Complete digestion of membrane bound CLIC4
was only achieved upon treatment with Triton X-100.
Direct evidence for the PTM has come from ﬂuorescence quenching,
ﬂuorescence energy transfer (FRET) and electron paramagnetic reso-
nance studies using site-directed cysteine scanningmutagenesis followed
by probe labelling. These studies directly show that CLIC1 integrates into
membranes [26,35] and that the PTM inserts into themembranewithdis-
tance measurements that are consistent with a TM α helix [35]. FRET
studies on CLIC1 in membranes have shown that the integral membrane
form consists of an oligomer, consistentwith a pore formed by the PTM in
a TM α helical conformation [35].
Although the evidence above indicates that CLIC1 can adopt an inte-
gral membrane form, not all membrane-associated CLIC proteins appear
to integrate into membranes. CLIC4 translocates to the plasma mem-
brane of NIE-115neuroblastoma cells (see Section4.1, below) [22]. How-
ever, the N-terminal epitope tag on CLIC4 did not protrude from the cell
[22] as might be expected by analogy to CLIC1 [55]. In a similar vein, the
C. elegans CLIC-like protein, Exc-4, resides exclusively on the luminal
membrane of the excretory cell (see Section 3.2.1, below) [17,18]. How-
ever, fusion constructs of Exc-4 that contain N-terminal GFP domains be-
have like wild type Exc-4 in localising to the luminal membrane and
rescuing the cystic phenotype of exc-4 null animals [17]. This suggests
that functional Exc-4 may not need to form a transmembrane protein.
CLICs interact with multiple cytoskeletal components [2,56] and
the ion channel activity of several CLIC family members is regulated
by cytoskeletal F-actin. When soluble recombinant CLIC1 or CLIC5
were inserted into planar lipid bilayers, their ion channel activity
was inhibited by F-actin, whilst that of CLIC4 was not [46].
2.2. ERM: ezrin, radixin and moesin
Like the CLICs, the ERM protein family is conserved throughout
metazoan evolution [57] with family members observed in thechoanoﬂagellates [58]. In vertebrates, there are three paralogues,
ezrin, radixin and moesin, hence the acronym ERM [59–61]. In
non-vertebrates there is usually only a single ERM protein. Although
their names differ, the proteins show high sequence identity (73–81%
among human ERM). ERM proteins are closely related to the NF2
tumor suppressor protein, Merlin, which shares the same architecture
and is also involved in membrane-cytoskeletal regulation [58].
ERM proteins have a three domain structure: a ~300 residue
N-terminal FERM domain [62,63]; a ~200 residue central α helical
coiled-coil domain which is sometimes followed by a proline-rich link-
er; and a ~100 residue C-terminal domain (called C-ERMAD) that con-
tains an F-actin binding site and a threonine (Thr567 in human ezrin)
which is phosphorylated on activation (Fig. 1D). The structure of an in-
active full-length ERM from the insect Spodoptera frugiperda has been
determined [64] (Fig. 1E) along with mammalian ERM structures of
the active FERM domains only of moesin [65], radixin [66] and ezrin
[67], and the dormant (inactive) complex of the FERM:C-ERMAD do-
mains of human moesin [68].
ERM proteins exist in two states: the dormant autoinhibited state
and the active state [69] (Fig. 2). In the dormant state, ERM is biologically
inert, as the functional binding sites on both the FERMandC-ERMADdo-
mains are masked by intramolecular interactions between the domains
[70]. On activation, these domains separate exposing functionally im-
portant binding sites on both FERM and C-ERMAD domains.
The mechanism of activation of ERM proteins is only partially un-
derstood. Two key steps are the phosphorylation of the conserved
threonine in C-ERMAD and the binding of the phospholipid phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2) by the FERM domain
[71–75]. These steps may be sequential, with PI(4,5)P2 binding pre-
ceding phosphorylation [75]. Thr567 (human ezrin numbering) has
been identiﬁed as the conserved C-ERMAD residue whose phosphor-
ylation coincides with activation [76]. On phosphorylation of Thr567,
the afﬁnity of C-ERMAD for the FERM domain is reduced while its af-
ﬁnity for F-actin remains unaltered [77,78]. Several kinases have been
implicated in ERM activation including: Rho-kinase (ROCK) [77], pro-
tein kinase Cθ [78,79] and protein kinase Cα [80].
In the active state, ERM proteins link membranes to the actin cyto-
skeleton. The free C-ERMAD binds to actin ﬁlaments [81]. The struc-
ture of this complex is not known, however, it has been suggested
that the last two residues of ezrin C-ERMAD are critical for interaction
with both FERM-domain in the dormant state and F-actin in the ac-
tive state [69].
On activation, the FERMdomain can bind tomembranes viamultiple
interactions. The FERM domain can bind directly to membranes via
binding speciﬁcally to the phospholipid PI(4,5)P2 (Fig. 1E, labelled
“Site 1”). It also binds directly to the cytoplasmic extensions of mem-
brane proteins [58] including: integrins, G protein coupled receptors
(GPCRs), cadherins, sialoglycoproteins (CD43 [82], CD44 [83]), adhesion
molecules (ICAM [84], VCAM), ATPases, selectin receptors (PSGL-1 [85])
and neutral endopeptidase [86] (Fig. 1E, Site 2). Finally, the FERM do-
main binds to scaffolding proteins that, in turn, bind to the cytoplasmic
tails of other integral membrane proteins [87–89] (Fig. 1E, Site 3).
Scaffolding proteins that bind ERM include: EBP50, also known as
NHERF1, and NHERF2 [70,90,91]. Both of these proteins consist of two
PDZ domains followed by a C-terminal ERM binding domain [92]. In
the dormant state of the scaffolding protein, the ERM binding domain
interacts with its own PDZ domain. On activation, the C-domain binds
to ERM while the two PDZ domains bind either the cytoplasmic tails
of integral membrane proteins or to other scaffolding proteins,
which, in turn, bind membrane proteins (Fig. 2).
ERM proteins play a key role in endocytosis, phagocytosis [93,94],
vesicular trafﬁcking and vesicle maturation [95]. Their function is to
organise the cortical actin structures so that they engulf particles or
cells, relocate the vesicles to sub-cellular regions and facilitate vesic-
ular fusion. In this role, they cooperate with Rho GTPases acting as
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Fig. 2. The activation of ERM proteins. The ERM proteins exist in two states: the dormant/inactive state and the active state. The activation of ERM proteins in vivo involves binding
to PI(4,5)P2 and phosphorylation of a conserved threonine residue in the C-ERMAD (Thr567 in human ezrin sequence numbering). The activation dissociates the FERM domain from
the C-ERMAD. Upon activation, the ERM proteins functions as a cross-linker by binding to (A) cytoplasmic extensions of membrane proteins (such as ICAM, CD43, CD44, NEP) and
(B) scaffolding proteins such as EBP50, which then bind to membrane proteins.
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The Ras superfamily of small GTPase proteins, including the Rho
GTPase family, are molecular switches that control many cellular pro-
teins and functions [97]. The members of this superfamily have a slow
intrinsic GTPase activity and hence their nucleotide state is largely
controlled by activating proteins (GAPs), nucleotide exchange factors
(GEFs) and nucleotide dissociation inhibitors (GDIs). The state of the
switch is determined by the bound nucleotide with the “on state” cor-
responding to bound GTP. The nucleotide controls the structure of
two regions called switch I and switch II. In the GTP-bound on state,
these two regions maintain a common structure which forms the in-
terface with binding proteins controlled by the small GTPase [98].
Thus these small GTPases directly activate the ﬁrst downstream part-
ners by binding through the switch I/switch II surface.
Small GTPases, including the Rho family, are membrane associated
proteins [99]. The interaction between the small GTPase and the
membrane is usually mediated by multiple weak interactions. These
include single or double covalent lipid modiﬁcation of the GTPase
(palmitoylation, myristoylation and/or prenylation) and polybasic or
polyproline regions that bind to negatively charged lipids [99]. The
activation of Rho GTPases enhances this membrane binding [99].
The Rho GTPases cycle between the cytosol, where they are maintained
in an inactive Rho-GDP form by binding to the nucleotide dissociation
inhibitor RhoGDI, and their site of action, the target membranes,
where they are in an active, Rho.GTP membrane-bound state [100].
The Rho family of small GTPases (Rho, Rac and Cdc42) control
membrane structure, dynamics and vesicle trafﬁcking by modulating
the actin cytoskeleton [101,102]. They act at various points in the
membrane:cytoskeletal interface including: control of actin assem-
bly/nucleation (DRFs, WAVE/WASP, coﬁlin and proﬁlin); proteins
that couple membranes to F-actin (ERM, EBP50, NHERF); proteins
that produce PI(4,5)P2 (PIP5K); the NADPH oxidase; and Rho kinase(ROCK). The CLIC proteins have also been linked to Rho GTPases
[12,22,34,103].
The control of the membrane:actin cytoskeletal interface contains
several feedback routes. Rho GTPases activate PIP5K, which produces
the phospholipid PI(4,5)P2. This, in turn, binds to several proteins ac-
tivated by Rho GTPases including coﬁlin, proﬁlin and ERM. Active
ERM binds to RhoGDI releasing Rho so it can bind GTP, thus, keeping
Rho GTPases in an active state, producing a positive feedback effect
[104]. Paradoxically, there also appears to be a negative feedback
loop between Rho GTPases and ERM [105].
2.4. NADPH oxidase
NADPH (nicotinamide adenine dinucleotide phosphate) oxidase is
the reactive oxygen species (ROS) generating oxidase. The founding
member NOX2 is predominantly expressed in phagocytes, such as mac-
rophages. In the resting state it is composed of the integral membrane
subunits gp91phox and p22phox and the soluble, cytosolic subunits
p67phox, p47phox, p40phox and Rac2, a Rho GTPase. Upon activation
by phagocytosing invading pathogens, the soluble subunits of the phox
complex, including Rac2, are recruited to phagosomal membranes
where they assemble with the membrane-bound subunits gp91phox
and p22phox to form an active oxidase complex [106]. Both p40phox
and p47phox proteins contain PX domains that target speciﬁc mem-
branes by binding the phospholipids phosphatidylinositol 3-phosphate
(PI(3)P) [107] and phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2)
[108], respectively.
A crucial step in the assembly and the activation of the NADPH
oxidase is the binding of Rac2 to p67phox. The cytosolic inactive
Rac.GDP-GDI complex dissociates upon activation in a strictly GTP de-
pendent manner, resulting in direct binding of active Rac.GTP to
p67phox via the all α helical structural tetratrico-peptide repeat
motif [109]. Recent evidence also shows that a low ROS environment
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mediate the reciprocal regulation between Rac and Rho. Aberrant Rac
and Rho activity has been linked to pathological conditions such as
cancer [110].
2.5. PI(4,5)P2 & PIP5K
Phosphatidylinositol-4-phosphate-5-kinase (PIP5K or PIPK5) is
a ~500 residue protein that catalyses the phosphorylation of
phosphatidylinositol-4-phosphate to PI(4,5)P2 (phosphatidylinositol
4,5-bisphosphate). PI(4,5)P2 controls the actin cytoskeleton by binding
to coﬁlin, proﬁlin and ERMproteins aswell as other proteins involved in
membrane:cytoskeleton interactions [111]. PI(4,5)P2 is involved in the
activation of ERM, as discussed above. PIP5K is regulated by Rac and
Rho, two members of the Rho family of small GTPases. Active PIP5K is
recruited to the membrane where it produces PI(4,5)P2. This, in turn,
maintains the active Rho-GTP state, providing positive feedback, as
described above.
Both PIP5K and PIP4K are structurally related membrane associated
proteins [112]. They are dimers with a ﬂat, basic surface that docks onto
amembrane. They have two binding pockets on the lipid surface so that
substrates only need to move ~1 Å out of the plane of the membrane
during catalysis. The proteins are stable, soluble proteins that only
bind weakly to membranes.
PIP5K is a mediator of phagocytosis [113]. Fine control over the
formation of a phagocytic cup is achieved by control of the spatial lo-
cation of phosphatidyl inositol phosphates: PI(4,5)P2 and PI(3,4,5)P3.
The nature of the phosphatidyl inositol phosphate determines which
proteins are bound to the phagosome membrane, thus, these phos-
pholipids orchestrate the phagocytic process.
The unstructured C-terminal region of the type Iβ PIP5K has been
shown to bind EBP50 in vitro, using puriﬁed proteins, and in HL-60
cells [114]. Additionally, yeast two hybrid screens suggest that there
may be an interaction between the unstructured C-terminal region of
the type 1β PIP5K and both CLIC1 and CLIC4 (http://www.signaling-
gateway.org, last accessed March 2013).
3. Setting the scene
3.1. Plasma membrane
3.1.1. Ezrin, microvilli & vesicular trafﬁcking
Ezrin was originally discovered as a component of microvilli from
intestinal epithelial cell brush borders [115]. It is associated with plas-
mamembrane regions containing densely packed actin ﬁlaments, cel-
lular structures such as: microvilli, rufﬂing membranes, cleavage
furrows, cell-cell and cell-substrate adhesion sites [63,116].
Ezrin knockout mice do not survive >1.5 weeks after birth, hence
conditional knockout [117,118] and knockdown [119] mice have been
generated. Ezrin is the only ERM protein detected in epithelial cells
of the developing intestine. Consequently, germline Ezrin−/− mice
displayed abnormal intestinal microvillus morphogenesis, however,
ezrin was not required for microvillus formation or epithelia
polarisation [117]. Ezrin may play an essential role in conﬁguring the
apical terminal web region that provides a platform for anchoring the
brush border microvilli and apical cell-cell junctions [117]. A similar
phenotype was observed when the ezrin gene deletion was targeted
only to adult intestinal epithelia [118]. This implies that ezrin is essen-
tial for both morphogenesis and homeostasis, particularly in the apical
junctional region, perhaps by controlling cortical architecture and re-
ceptor distribution and activation.
The ezrin knockdown mice show severe growth retardation with
only 7% surviving to adulthood [119]. These survivors showed no
gross histological abnormalities with normal intestinal epithelial
cells, well-formed intestinal villi as well as normal microvillar struc-
tures. The surviving ezrin knockdown mice suffered from severeachlorhydria (loss of gastric acid secretion) [119]. These mice have
b5%of normal ezrin protein levels in their stomachswithout compensa-
tory upregulation of radixin or moesin. In the wild type (WT) mice, the
parietal cells of the stomach are characterised by a meandering invagi-
nation of the apical surface called the secretory canaliculus [119]. This
surface bears themicrovilli. Underneath this, the parietal cell cytoplasm
is densely packed with tubulovesicles. The parietal cells in the ezrin
knockdownmice contain the tubulovesicles but not the invaginated se-
cretory canaliculus.
Histamine stimulation of parietal cells fromWTmice resulted in in-
creased invaginations in the canaliculus, with a concomitant decrease in
the density of underlying tubulovesicles [119]. In contrast, histamine
stimulation of ezrin knockdown parietal cells did not result in the for-
mation or expansion of the canalicular apical membranes and the cyto-
plasm remained densely packed with tubulovesicles [119].
These observations link the structure of the microvillar apical
membrane with cytoplasmic tubular vesicles. This suggests that the
defect caused by the reduction in ezrin may be related to the trafﬁck-
ing and fusion of the underlying tubulovesicles to the apical plasma
membrane where they would increase the surface area and hence re-
sult in formation/expansion of the canalicular apical membrane.
3.1.2. CLIC5, ERM, the actin cytoskeleton & microvilli
The ﬁrst indication of an association between CLIC proteins and
ERM came with the discovery of CLIC5 in pull-down assays from ex-
tracts of placental microvilli using the ezrin C-ERMAD domain as
bait [2]. Additionally, CLIC5 and ezrin colocalised to the apical micro-
villi of JEG-3 choriocarcinoma cells [120]. A complicating factor in the
pull-down assay was that portions of the actin cytoskeleton were also
pulled down, including actin, gelsolin, IQGAP1, α-actinin and ezrin it-
self. However, using latrunculin as an actin polymerisation inhibitor,
subsequent pull-down studies conﬁrmed the binding of ezrin to
GST-CLIC5, with a reduced level of actin and α-actinin binding. The
authors suggested that CLIC5 binds directly to ezrin, but not to the
C-ERMAD [120].
3.1.3. CLIC5, radixin & stereocilia
The naturally occurring Jitterbug mouse has a mutated CLIC5 gene
(Clic5−/−) resulting in the absence of detectable CLIC5 protein ex-
pression [121]. These mice have progressive deafness and vestibular
dysfunction (loss of balance) associated with hair cell stereocilia de-
generation. The stereocilia of the inner ear are microvillar structures
that protrude from the apical surface of the hair cells and are respon-
sible for hearing and balance. Like other microvilli, the stereocilia are
based on bundles of cross-linked actin ﬁlaments that are anchored to
a terminal web and the membrane at the tip of the villi.
In normal mice, CLIC5 is highly expressed and colocalised with
radixin in both cochlear and vestibular hair cell stereocilia [121]. In
hair cells of the chicken utricle, CLIC5 is expressed with radixin at 1:1
molar ratio [121]. CLIC5 is also localised to the microvilli-covered apical
surfaces of interdental cells and columnar cells of Kolliker's organ
(a transient structure in the developing mammalian cochlea). In con-
trast, CLIC5 could not be detected in the inner ear of Clic5−/− mice
and radixin expression was diminished [121]. Interestingly, mutations
in the radixin gene are associated with nonsyndromic hearing loss in
humans [122].
Ezrin, like radixin, is also present in the hair cell stereocilia [123,124].
In young Rdx−/−mice, both cochlear and vestibular stereocilia develop
normally. However as the mice reach adulthood, cochlear stereocilia
degenerated (as per the Clic5−/− mice), indicating that radixin is re-
quired for maintenance of cochlear stereocilia. This suggests that ezrin
compensates for radixin during stereocilial development and vestibular
stereocilial maintenance [123]. The fact that jitterbugmice exhibit both
inner ear and vestibular dysfunction suggests that CLIC5 interacts with
both radixin and ezrin to maintain healthy hair cell stereocilia.
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The podocyte cells of renal glomeruli create theﬁltration barrier that
prevents high molecular weight components of blood from diffusing
into urine. Each podocyte creates a comb-like structure comprising
long, thin, actin-ﬁlled extensions of the cytoplasm called foot processes
[125]. The ﬁltration barrier is formed by the specialised “zipper-like”
cell-cell junctions between adjacent foot processes [126]. Podocalyxin
is a podocyte apical membrane sialoglycoprotein which binds ezrin
and the scaffolding protein NHERF1. The Rho family GTPase Cdc42 is
critical for the maintenance of the ﬁltration barrier structure [127]. In
cultured MDCK cells ezrin recruits RhoGDI, facilitating the activation
of Rho GTPases [128].
CLIC5 and ezrin localise to the podocyte foot processes and are
essential for healthy kidney function [129,130]. CLIC5 is highly
expressed in podocytes and endothelial cells of glomeruli [131],
while ezrin connects the cytoplasmic tail of podocalyxin to the actin
cytoskeleton [132,133]. CLIC5 colocalises with ezrin and podocalyxin
in glomeruli and coimmunoprecipitates with podocalyxin from a glo-
merular lysate.
In addition to the defects in hearing and balance discussed above,
Clic5−/− jitterbug mice have proteinuria [130] with broadened
podocytes and vacuolisation of their glomerular endothelial cells [129].
Western blots of glomerular lysates from jitterbug mice show that
ezrin expression level is reduced compared to wild type. Additionally,
the colocalisation of ezrin andpodocalyxin in podocytes is reduced in jit-
terbug glomeruli, breaking the link between podocalyxin and actin. Dis-
sociation of podocalyxin from the actin cytoskeleton is associated with
the loss of podocyte structural integrity [133]. Hence, CLIC5 plays a
role in maintaining both structure and function of the podocyte by facil-
itating the interaction between ezrin and podocalyxin.3.1.5. CLIC4, ezrin & the apical microvilli of the occular retinal pigment
epithelium
The retinal pigment epithelium (RPE) of the eye is a layer of
pigmented cells sandwiched between the photoreceptors and the
choriocapillaries [134]. This layer serves as a blood-retina barrier. The
apical side of theRPE faces the photoreceptors and develops longmicro-
villi that interdigitate into and tightly embrace the light sensing outer
segments of the photoreceptors. The RPE phagocytoses the decayed
disks of the photoreceptors.
Ezrin is important for the maintenance of the RPE microvilli. Re-
ducing the expression of ezrin in primary cultures of rat RPE de-
creased the length and number of apical microvilli and the elaborate
basal infoldings typical of these cells [135]. Further, Ezrin−/− mice
bear similar morphological changes in RPE [136].
Like Ezrin, CLIC4 is also enriched in the apical microvilli of RPE
[134]. Using in vivo retinal transfection, the silencing of CLIC4 in rat
RPE resulted in changes similar to that of ezrin knockdown or gene
deletion. They displayed loss of apical microvilli and basal infoldings,
reduced retinal adhesion and epithelial-mesenchymal transition
[134]. CLIC4 suppression also resulted in severe dysplasia in adjacent
neural retinas, suggesting it is critical for retinal epithelial morpho-
genesis [134]. Unexpectedly, high level of the water channel,
aquaporin 1, appeared at the apical surfaces of cells in which CLIC4
expression was suppressed.3.2. Intracellular membranes & tubulogenesis
Tubulogenesis is a fundamental cellular process needed for the de-
velopment of tubules in organs such as kidneys, lungs and blood ves-
sels. Tubules arise from the hollowing of polarised epithelial or
endothelial cells and involve extensive cytoskeletal reorganisation
and membrane trafﬁcking [137,138]. Not surprisingly, ERM proteins
and Rho GTPases are critical regulators of tubulogenesis [139].3.2.1. Exc phenotype in C. elegans: CLIC-like proteins, ERM, Rho &
cytoskeleton
In the nematode, C. elegans, the excretory cell forms an “H”-like
structure that runs the length of the worm. Inside this cell, there is
a tubular, apical membrane-bound compartment into which wastes
are excreted. The worm excretory system has been used as a model
for the kidney.
In 1999, a series of mutants was described where this apical mem-
brane domain, the excretory canal, was defective, usually forming
cysts [140]. Nine exc mutants (exc-1 through exc-9) and mutations
of several other genes can cause this phenotype. Some of the proteins
now known to cause this mutation include: Sma-1–β spectrin [140];
Exc-5–FGD1, a GEF for Cdc42 [141–143]; Exc-7–ELAV, a splicing fac-
tor that binds mRNA for Sma-1 and Exc-3 [144,145]; and Exc-9–
Zn-binding LIM domain protein [146].
The discovery that Exc-4 was a member of the CLIC protein family
was a major advance in understanding CLIC function [17,18]. Unlike
mammalian CLICs, Exc-4 does not have a detectible cytosolic compo-
nent but lines the apical tubular membrane in the excretory cell and
is completely membrane associated. The key determinant for mem-
brane binding is helix h1 [16], which corresponds to the putative
TM domain in human CLICs [17,18]. Disruption of Exc-4 results in a
cystic enlargement of the interior lumen of the canal of the excretory
cell. Despite this, the precise mechanism by which exc4 mutations
maintain the integrity of the excretory canal is not known.
Some of the other excmutations have functions that might intersect
with that of Exc-4 as they are involved in membrane turnover or
remodelling. For example, the GEF Exc-5 regulates the Rho GTPases,
Cdc42 and Rac, in a manner that controls endosome recycling [141].
When Exc-5 is disrupted, early endosomes concentrate near the apical
membrane while recycling endosomes are depleted. Conversely, the
over-expression of Exc-5 results in enrichment of recycling endosomes.
It is thought that endosome recycling is important for maintaining the
integrity of the luminal membrane.
C. elegans has a single ERM protein, ERM-1 which has an essential
role in lumen morphogenesis [147,148]. Disruption of the erm-1 gene
results in a cystic luminal phenotypes like that in the Exc mutants.
ERM-1 interacts with the cytoskeletal proteins, β spectrin (Sma-1)
and actin 5, in maintaining the luminal membrane [147]. Further,
ERM-1 recruits the water channel, AQP-8, to the excretory cell
lumen and this channel is important in directly controlling ﬂuid pres-
sure across the membrane [149].
3.2.2. CLIC4 & tubulogenesis
In tubulogenesis, lumen formation and expansion require apical
membrane biogenesis and serial intracellular vacuole and vesicle fusion
events [150,151]. Compared to the near neutral cytosolic pH, vesicles
are acidic with a varying pH that is regulated by a number of ion chan-
nels and transporters such as the vacuolar H+ ATPase (v-ATPase).
v-ATPase utilizes the energy of ATP hydrolysis to translocate protons
across membranes resulting in a lowered luminal pH and an inside-
positive transmembrane potential. Thus, sustaining v-ATPase activity
requires a parallel counterion transport to compensate the charge
build up. Chloride ion regulation through chloride channels and trans-
porters including the CLICs are suggested to play an important part in
providing these counterions [152].
Supporting a role for CLICs in counterion regulation, Clic4−/−mice
that display defective angiogenesis also have impaired vacuolar acid-
iﬁcation [153]. In tubulating endothelial cells, the average pH of large
vacuoles is about 0.3 pH units higher in Clic4−/−mice. There is no pH
difference in the small vesicles that resemble lysosomes. Both the
CLIC channel blocker IAA94 and the v-ATPase inhibitor baﬁlomycin
A1 caused impairment in WT endothelial cell vacuolar acidiﬁcation,
supporting the involvement of both proteins in this process [153].
The outcome of impaired angiogenesis is that Clic4−/− mice have re-
duced arterial collaterals in skeletal muscle and brain [154], a process
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4. Action!
Implicit in the scenarios above is the dynamic nature of the cellu-
lar processes involving CLIC and ERM. Below, we examine cellular
processes where the dynamics are explicit.
4.1. CLIC4, NHERF2, RhoA & translocation to the plasma membrane
A dramatic movement of CLIC4 to the plasma membrane was ob-
served in NIE-115 neuroblastoma cells on stimulation with either
lysophosphatidic acid (LPA), thrombin receptor activating peptide or
sphingosine-1-phosphate [22]. This was observed statically, using im-
munoﬂuorescence and endogenous CLIC4, and dynamically, using live
cell imaging in cells expressingGFP-CLIC4. CLIC4movement to the plas-
ma membrane was dependent on Gα13-mediated RhoA activation and
F-actin integrity, but not Rho kinase activity [22] and was coincident
with recruitment of NHERF2 to same sites. As NHERF2 is an ERM
binding scaffolding protein, this suggests the involvement of ERMs in
this process.
The putative enzymatic site for CLIC4 centres on Cys35, which is
equivalent to Cys24 in CLIC1 (Fig. 1A & B). Any mutations around this
site blocked CLIC4 membrane recruitment and prevented NHERF2
colocalisation [22]. This suggests that CLIC4 may possess a Cys-
dependent transferase activity which is linked to its translocation to
the plasma membrane sites.
4.2. CLIC1, amyloid & translocation to the plasma membrane
Inmicroglial BV2 cells, the addition of amyloid Aβ peptide produced
a translocation of cytoplasmic CLIC1 to the plasmamembrane, presum-
ably to the site of amyloid particle ingestion [27]. The movement of
CLIC1 was associated with increased CLIC1 ion channel activity in the
plasma membrane [155], as well as NADPH oxidase mediated produc-
tion of ROS [27].
4.3. CLIC1, ERM, Rho, Rac & phagocytosis
CLIC1 is highly expressed in macrophages, which are key cells in
innate and adaptive immunity. In resting macrophages, CLIC1 appears
as punctate structures with a dense perinuclear distribution [34]
(Fig. 3). Although this distribution is similar to known vesicles, the
CLIC1 structures do not co-localise with markers for early endosomes
(EEA1), transferrin-positive endosomes, late endosomes (LBPA), lyso-
somes (LAMP1) or recycling endosomes (Rab11) [34].
Macrophages ingest pathogens, foreign particulates or apoptotic
cells by phagocytosis to form phagosomes. During the course of
phagocytosis, phagosomes mature progressively by fusion with acidic
early and late endosomes, as well as lysosomes, resulting in progres-
sive phagosomal acidiﬁcation [156,157]. The process of phagosome
maturation is in part dependent on Rho GTPases and ERM proteins,
both of which are regulators of the reorganisation of the actin cyto-
skeleton [94].
Phagocytosis of serum opsonised zymosan particles by macro-
phages results in complex, rapidly occurring changes to plasma and
intracellular membranes. On initiation of this process, the small
GTPases, Rac2 and RhoA, translocate to the phagosomal membrane
[94], which is followed rapidly by translocation of CLIC1 and ERM
[34] (Fig. 3D-L). Clic1−/− mice display a small but consistent defect
in phagosomal acidiﬁcation of about 0.2 pH units [34]. This pH differ-
ence could be reproduced in WT but not Clic1−/−macrophages using
the CLIC ion channel blocker IAA94. The pH increase in knockout cells
was not due to altered phagosomal-lysosomal fusion. This data bearsstrong similarity to the changes in vesicle pH described in CLIC4 −/−
endothelial cells during tube formation [153].
Consistent with an effect on phagosomal pH, Clic1−/− macro-
phages also show impaired phagosomal proteolysis and attenuated
ROS production. Further, Clic1−/− mice were almost completely
protected from arthritis development in the K/BxN serum transfer ar-
thritis, a disease model of chronic inﬂammation that is dependent on
innate immune cells like macrophages [158].4.4. CLIC3 & the sorting/recycling of intracellular vesicles
Endosome trafﬁcking is important in the recycling of cell surface
receptors/proteins. Receptor-ligand interaction often results in
internalisation of the complex into endosomes which may then either
fuse with lysosomes, resulting in the degradation of their cargo, or be
recycled to the plasma membrane. Studies in an ovarian cancer cell
line show that the small GTPase, Rab25, is important in directing
endosomes containing active α5β1 integrin to lysosomes [159].
Rab25 also upregulates CLIC3 which then colocalises with active
α5β1 on late endosomes/lysosomes. Both CLIC3 and the acidiﬁcation
of the late endosome/lysosome are essential for the recycling of the
active α5β1 integrin to the plasma membrane.
Similar ﬁndings were obtained by silencing a sialidase, NEU3, in
renal carcinoma cells [160]. NEU3 regulates β1 integrin trafﬁcking by
controlling recycling. Silencing NEU3 upregulated Rab25, directing
internalised integrins to lysosomes, and downregulated CLIC3, blocking
recycling to the plasma membrane [160].
Studies using a peptide, CLT1, that binds to tumour interstitial
spaces showed that when the peptide aggregated with ﬁbronectin,
it promoted the translocation of CLIC1 to the endothelial cell surface
via ligation to integrinα5β3 [161]. The internalisation of this complex
led to tumour cell death. When added to bladder tumour cell lines
[162], this peptide induced autophagic tumour cell death that was de-
pendent on the integrin α5β1 and CLIC3. These authors propose that
the internalisation of the CLT1-ﬁbronectin complex results in lyso-
somal dysfunction which triggers autophagy [162].
Pathogens such as Listeria monocytogenes can survive in macro-
phages after being phagocytosed. The killing of these pathogens re-
quires bacteria to be opsonised by the complement product, C3b
[163]. This killing activity is effected by the fusion of phagosomes
with lysosomes. CLIC3 was necessary for phagosome-lysosome fusion
and is responsible for an increase in chloride ion concentration in the
phagosome from ~30 mM to ~100 mM and was independent of
phagosomal acidiﬁcation [163].5. Is there a smoking gun?
A common thread in all the observations above is that CLIC
and ERM proteins are often involved in membrane remodelling
processes that also involve the actin cytoskeleton and small, usually
Rho, GTPases. Some of these processes involve specialised plasma
membrane structures such as microvilli, stereocilia and podocytes,
while others involve the formation of membrane vesicles (phagocy-
tosis) or vesicle trafﬁcking (phagosome-lysosome fusion, endosome
recycling). In some of the processes that involve specialised plasma
membrane structures, the underlying mechanism may involve the
trafﬁcking of vesicles from the underlying cytoplasm to the plasma
membrane.
This suggests that CLIC and ERM proteins may interact, directly or
indirectly, to facilitate actin-mediated membrane remodelling. De-
spite this, there is no compelling evidence for a strong, direct interac-
tion between CLIC and ERM proteins, or between these proteins and
Rho GTPases or PIP5K. In part, the lack of direct evidence may be















Fig. 3. Subcellular distributions of CLIC1, ERM & RhoGTPases during phagocytosis. Protein subcellular localisation in macrophages as shown by ﬂuorescence confocal microscopy. A:
In resting macrophages, CLIC1 appears in confocal immunostaining images as punctate, unidentiﬁed vesicle-like cytoplasmic structures with a dense perinuclear distribution. B:
These are similar to the early endosome marker EEA1. C: In the periphery of the cell where the cytoplasm is thin, it is clear that CLIC1-containng structures do not colocalise
with the EEA1 positive early endosomes. When macrophages ingest serum opsonized zymosan particles (panels D to L), CLIC1 translocates to phagosomal membrane (D, G, J)
where it appears to colocalise with ERM (E, F), Rac2 (H, I) and RhoA (K, L). The nucleus is shown in blue (A, B, C) after staining with To-Pro-3. Bar = 5 μm.
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Many proteins at the membrane:cytoskeletal interface interact
weakly with each other and with membranes. However, when multi-
ple weak interactions involve a common target, such as a membrane
or multiple sites on a single protein, they can produce strong overall
binding [164].
The prevalence of such multiple weak interactions at the mem-
brane has led to the concept of coincidence signalling, where the
presence of two or more membrane bound species (proteins or
lipids) is needed to produce a high afﬁnity complex with an effector
protein [165]. This may explain aspects of Rho signalling and the
regulation of Rho by GEFs and PIP5K by Rho.
The use of multiple weak interactions in coincidence signalling has
many advantages. It allows ﬁne control, where breaking a single weak
interaction reduces the afﬁnity of the whole signalling complex. It al-
lows for signal integration, where multiple inputs are needed for sig-
nal transmission. This allows for circuit expansion, where commonsignalling components can be rearranged and reused to create new
networks.
5.2. Do Rho GTPases activate ERM by direct binding?
A clue to how the ERM system is activated by Rho GTPases comes
from studies of the sorting nexins, SNX17, SNX27 and SNX31, a family
of phox-homology domain containing proteins that are involved in ves-
icle trafﬁcking [166–168]. The SNX proteins contain a FERM-like do-
main where FERM subdomain F1 is homologous to a Ras-association
domain. Only active GTP-bound Ras proteins bind to the SNX FERM
domain, however, this binding is weak (~20 μM) [166,167].
Recently, the crystal structure of the complex between the FERM
domain of KRIT1 and the small GTPase Rap1 has been reported
[169]. This structure conﬁrms the predictions based on the sorting
nexins. The interface includes the switch I and switch II regions mak-
ing the interaction sensitive to the presence of GTP. Thus, it is likely
that many FERM domain proteins are effectors of small GTPases.
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similar, weak, direct complexes in solution. In order to form a high
afﬁnity complex, the missing component may be the membrane,
which would have multiple attachment sites for ERM (via cytoplasmic
domains of integral membrane proteins and charged phospholipids)
and for the active Rho.GTP complex.
5.3. Unstructured cytoplasmic domains: “string binding”
Integral membrane proteins often have unstructured cytoplasmic
domains or “strings”. These strings acquire structure when they
meet their target binding protein. The ERM FERM domain binds
such cytoplasmic string domains of membrane proteins. The scaffold-
ing proteins including EBP50 and NHERF do likewise, extending the
number of strings attached to the ERM:scaffolding protein complex.
This increases the number of interactions between membrane com-
ponents and the scaffolding complexes, which is consistent with the
notion of multiple weak interactions and coincidence signalling.
CLIC proteins may also bind extended string domains. One unusual
feature of the CLIC protein structures is the presence of an open slot
that includes the putative active site [13,20,22,30,32,170]. This slot
could accommodate an extended polypeptide chain and, indeed, nor-
mally unstructured regions of neighbouring CLIC molecules lie in this
slot so as to form crystal contacts [30,32]. It is possible that the targeting
of CLIC proteins to membrane surfaces either with or without CLIC en-
zymatic activity, involves binding to cytoplasmic, unstructured regions
of membrane proteins. This might explain why mutagenesis of the
CLIC4 active site prevented its membrane localisation after GPCR stim-
ulation and subsequent Rho activation [22].Fig. 4. Speculative model for assembly of CLIC-ERM-Rho complexes on membranes. A: The dorm
EBP50 are in their inactive states and CLIC proteins are in the cytoplasm. B, C & D. Three pos
PIP5K and CLIC. Active PIP5K produces PI(4,5)P2. Rho.GTP also binds ERM, helping in its activ
EBP50, which binds to cytoplasmic domains of integral membrane proteins. ERM binds to R
variant of B where CLIC binds to ERM as well as PIP5K resulting in the formation of a large co
producing and integral membrane CLIC protein which may have ion channel activity.5.4. Are CLIC proteins soluble, cytoplasmic proteins or are they components
of intracellular vesicles?
The nature of the cytoplasmic pool of CLIC proteins is unresolved. In
C. elegans, there appears to be little free cytoplasmic CLIC (Exc-4), with
the majority of the protein residing on the apical luminal membranes.
Mammalian CLIC proteins have no signal sequence and are synthesised
in the cytoplasm.Most of themammalian CLIC protein resides in the cy-
toplasm, however, it is not clear as to whether this is as a soluble pro-
tein, or bound to vesicles. The immunoﬂuorescence imaging studies
of CLIC1 in Panc 1 (human pancreatic carcinoma epithelial-like) cells
[171], platelets [103] and macrophages [34] (Fig. 3) all show punctate
staining that is densely packed in theperinuclear region. This is reminis-
cent of endosomes and other intracellular vesicles. In contrast, studies
using overexpressed CLIC-GFP fusion proteins display a diffuse staining
pattern, for example, CLIC1-eGFP in BV2 cells [27] and GFP-CLIC4 in
NIE-115 neuroblastoma cells [22]. Determining the nature of the cyto-
plasmic pools of CLIC proteins (vesicle bound versus soluble) will help
advance our understanding of the molecular mechanisms involved in
CLIC biology.
5.5. Do CLIC proteins function as ion channels in intracellular vesicles?
The most direct evidence to date of physiologically relevant ion
channel activity comes from our studies on macrophage phagocytosis
where Clic1−/− phagosomes were defective in acidiﬁcation [34]. The
simplest interpretation of the difference between phagosomal pH
when comparing Clic1−/− to WT is that CLIC1 acts as an ion channel,
compensating for the change in membrane potential as the luminalant state prior to signalling. Rho.GDP is bound to RhoGDI, and hence inactive. ERM and
sible scenarios for the active, signalling state. B: Rho.GTP binds the membrane, recruits
ation via a kinase. EBP50 is also activated. ERM binds to PI(4,5)P2 on the membrane and
hoGDI, ensuring continued activity of Rho. ERM C-ERMAD recruits F-actin. C: This is a
mplex on the membrane. D: is a variant on C where CLIC integrates into the membrane
653L. Jiang et al. / Biochimica et Biophysica Acta 1838 (2014) 643–657pH decreases. Further, these mice displayed no defect in phagosome-
endosome fusion that might otherwise account for the altered pH.
This data is consistent with the acidiﬁcation defect in the large vacuoles
of Clic4−/− endothelial cells [153] and the lowered intra-endosomal
chloride concentration in Clic3−/− bone marrow derived macrophages
[163]. However, without direct mechanistic information for how these
pH/chloride ion differences occur, it is impossible to be certain that a di-
rect ion channel function of the CLIC proteins is responsible.5.6. A speculative model for the assembly of a membrane-bound complex
including CLIC, ERM, RhoGTPase
Drawing on all the data above, we propose speculative models for
what is occurring at the membrane surface involving CLIC proteins,
ERM and Rho GTPases. Initially, the membrane is free of CLIC, ERM,
Rho and the scaffolding proteins (Fig. 4A). Rho GTPases may form com-
plexes with RhoGDI, maintaining them in the inactive Rho.GDP state. A
cellular signal initially activates a Rho GTPase, moving it from its cyto-
plasmic Rho.GDP state to its membrane-bound Rho.GTP state. This acti-
vates PIP5K, producing PI(4,5)P2 locally in the membrane (Fig. 4 B, C &
D). Active RhoGTP binds ERM, which is phosphorylated by a kinase
(either ROCK or another kinase). ERM adopts its active conﬁguration
and binds to the membrane via PI(4,5)P2. It binds to actin ﬁlaments
with its free C-ERMAD. ERM recruits scaffolding proteins and togetherFig. 5. Speculative model where CLIC is involved in recruiting vesicles. Cytoplasmic CLIC protei
lies in the perinuclear region. B: On Rho activation, proteins assemble at the site of activatithey bind the cytoplasmic tails of integral membrane proteins causing
them to cluster.
The question is: where is CLIC in this process? Some experimental
data shows that CLICs move to themembrane on Rho activation. There-
fore, one possibility is that CLICs binds to membrane-associated PIP5K
as suggested by the yeast twohybrid screens, by binding to the unstruc-
tured C-terminal domain of PIP5K (Fig. 4B). A second possibility is that
the CLIC binds directly to ERM, potentially linking the ERM complex to
PIP5K (Fig. 4C). It is not clear whether CLIC proteins bind to the mem-
brane as part of a complex or whether they integrate into the mem-
brane, possibly forming an ion channel (Fig. 4D). The cytoplasmic
state of CLIC proteins are still unresolved. If CLICs are bound to
perinuclear vesicles in quiescent cells, Rho activation may recruit
CLIC-associated vesicles to the site of activation (Fig. 5).6. Conclusion
The interface between the actin cytoskeleton and membranes is
highly dynamic and tightly controlled. Many of the participating
proteins interact with each other and the membrane via multiple
weak interactions. These include interactions with PI(4,5)P2 which is
also a major signalling molecule. The resulting cellular signals are likely
to occur via coincidence or integrated signalling. This allows maximal
control and versatility in signalling. Many of the integral membranens may reside in/on intracellular vesicles. A: In the quiescent state, vesicle-bound CLIC
on and CLIC containing vesicles are transported to the site of activation.
654 L. Jiang et al. / Biochimica et Biophysica Acta 1838 (2014) 643–657proteins in these signalling complexes provide “strings” – unstructured
peptides – that adopt a well-deﬁned three dimensional structure only
when they bind to target proteins such as the ERM FERM domain or
the NHERF PDZ domains.
The CLIC proteins and the ERM family appear to be linked in
maintaining the structure and dynamics of the membrane:actin cyto-
skeleton interface. They are controlled by the Rho GTPases and, in
turn, control Rho, providing feedback stabilisation. CLIC and ERM ap-
pear to be important in determining the fate of intracellular vesicles —
to fuse or not to fuse, to return to the plasma membrane or not. This
may facilitate their control over plasma membrane structures such as
microvilli, where they may be acting as a source of plasma membrane
material rather than directly stabilising static structures. The molecular
mechanism by which CLICs and ERMs cooperate in this is yet to be
discovered.
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